Response To: "Utility of Endogenous 4β-hydroxycholesterol As a Biomarker to Assess Cytochrome P 450 3A (CYP3A) Activity: Not Quite Ready for Prime Time"
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Dalgard Dunvald A, Soltoft K, Sheetal E, Just S, Frederiksen I, Nielsen F Eur J Clin Pharmacol. 2023; 79(12):1687-1698.
PMID: 37831074 PMC: 10663184. DOI: 10.1007/s00228-023-03578-1.
References
1.
Penzak S, Rojas-Fernandez C
. 4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation. J Clin Pharmacol. 2019; 59(5):611-624.
DOI: 10.1002/jcph.1391.
View
2.
Fuhr U, Jetter A, Kirchheiner J
. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach. Clin Pharmacol Ther. 2007; 81(2):270-83.
DOI: 10.1038/sj.clpt.6100050.
View
3.
Rogers J, Rocci Jr M, Haughey D, Bertino Jr J
. An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity. Clin Pharmacol Ther. 2003; 73(3):153-8.
DOI: 10.1067/mcp.2003.23.
View
4.
Kvitne K, Hole K, Krogstad V, Wollmann B, Wegler C, Johnson L
. Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range. Eur J Clin Pharmacol. 2022; 78(8):1289-1299.
PMC: 9283167.
DOI: 10.1007/s00228-022-03336-9.
View
5.
Gjestad C, Hole K, Haslemo T, Diczfalusy U, Molden E
. Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol-an Interaction Study in Healthy Volunteers. AAPS J. 2019; 21(4):58.
DOI: 10.1208/s12248-019-0330-1.
View